Home > Deininger Lab > Michael Deininger Recognition

deiningerlabheader-anim2

deiningerSidebar

Recognition - Michael Deininger

Dr. Deininger chairs a panel discussion on "Newly Diagnosed CML." 

Podcasts
Podcast of Dr. Deininger discussing updates to CML treatment.

Press Releases

FDA approves ponatinib following studies by Deininger and colleagues

Dr. Deininger named Chief of Hematology and Hematologic Malignancies, September 2010

Dr. Deininger welcomed to The University of Utah, September 2010

Affiliations
1982-1990
1995-1997
1998-1999
2004-2006
2008-present
Scholar of the German Scholarship Foundation
Fellow of the Mildred Scheel Foundation/German Cancer Aid
Scholar of the Dr. Ernst and Anita Bauer Foundation
Scholar of the American Society of Hematology
Scholar in Clinical Research of the Leukemia and Lymphoma Society
Honors
2000-present
2007-present
2008-present
Member, American Society of Hematology
Member, American Society of Clinical Oncology
Member, Editorial Board of Blood
Contact Tony Pomicter at  This e-mail address is being protected from spambots. You need JavaScript enabled to view it or 801-587-4640

Cancer Types and Topics

Deininger Lab


make appt button
clccancerquestions
Get the HCI E-NEWSLETTER
enter your e-mail address below:
 
youtube_icon